MedPath

Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital

Completed
Conditions
COVID-19
Registration Number
NCT04380792
Lead Sponsor
Manuel Monreal
Brief Summary

The main objectives are:

* To establish the prevalence of deep venous thrombosis through ultrasonography in Patients infected with COVID-19 admitted to hospital.

* To identify patients with higher risk of deep venous thrombosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2497
Inclusion Criteria
  • Patients infected with COVID-19.
  • Admission to hospital.
Exclusion Criteria
  • Patients treated with ECMO (Extracorporeal membrane oxygenation).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
VTE events and complications30 days

Study endpoints are clinically recognized (and objectively confirmed) recurrences of VTE, major and minor bleeding complications, and death.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Manuel Monreal

🇪🇸

Badalona, Barcelona, Spain

Manuel Monreal
🇪🇸Badalona, Barcelona, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.